Global Biologics Contract Development and Manufacturing Organization (CDMO) Market is accounted for $9.93 billion in 2020 and is expected to reach $25.48 billion by 2028 growing at a CAGR of 12.5% during the forecast period. Rising number of pharmaceutical and biopharmaceutical companies in the emerging economies, high demand for novel therapeutics applications, and increasing demand for small molecules and biologics are the major factors propelling the market growth.
Request for a Free Sample Copy of Report at www.strategymrc.com/report/biologics-contract-development-and-manufacturing-organization-cdmo-market/request-sample
By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to the growing number of pharmaceutical companies in emerging economies such as India and China. In particular, global companies are choosing India owing to the high production of biosimilars in the country. Moreover, the low cost of manufacturing activities and skilled labor are the major factors drivers of this market region.
Some of the key players profiled in the Biologics Contract Development and Manufacturing Organization (CDMO) Market include AbbVie Contract Manufacturing, AGC Biologics, Binex Co. Limited, Boehringer Ingelheim Group, Catalent Inc., Fujifilm Diosynth Biotechnologies USA Inc., JRS Pharma, Lonza Group, Parexel International Corporation, PRA Health Sciences, Rentschler Biotechnologies, Samsung Biologics, Sandoz Biopharmaceuticals (Novartis AG), Toyobo Co. Limited, and Wuxi Biologics.
Types Covered in Biologics Contract Development and Manufacturing Organization (CDMO) Market
• Non-mammalian (Microbial)
• Contract Manufacturing Organization (CMO)
• Contract Research Organization (CRO)
• Big Pharma
• Generic Pharma
• Small Pharma
If Any Query? Ask Our Industry Expert at www.strategymrc.com/report/biologics-contract-development-and-manufacturing-organization-cdmo-market/request-customization
Explore the list of attractive markets during this time of Pandemic @ www.strategymrc.com/covid-19-impact-reports
StrategyMRC research reports and publications are routed to help clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. We track 30+ industries and cover 800 market segments.
Stratistics Market Research Consulting